Cite
Comparison of outcomes between Hodgkin's lymphoma patients treated in and outside clinical trials: A study based on the EORTC‐Dutch late effects cohort‐linked data.
MLA
Juul, Sidsel Jacobsen, et al. “Comparison of Outcomes between Hodgkin’s Lymphoma Patients Treated in and Outside Clinical Trials: A Study Based on the EORTC‐Dutch Late Effects Cohort‐linked Data.” European Journal of Haematology, vol. 110, no. 3, Mar. 2023, pp. 243–52. EBSCOhost, https://doi.org/10.1111/ejh.13899.
APA
Juul, S. J., Kicinski, M., Schaapveld, M., Rossetti, S., Aleman, B. M. P., Liu, L., van Leeuwen, F. E., Meijnders, P., Krol, A. D. G., Janus, C. P. M., Hutchings, M., & Maraldo, M. V. (2023). Comparison of outcomes between Hodgkin’s lymphoma patients treated in and outside clinical trials: A study based on the EORTC‐Dutch late effects cohort‐linked data. European Journal of Haematology, 110(3), 243–252. https://doi.org/10.1111/ejh.13899
Chicago
Juul, Sidsel Jacobsen, Michal Kicinski, Michael Schaapveld, Sára Rossetti, Berthe M. P. Aleman, Lifang Liu, Flora E. van Leeuwen, et al. 2023. “Comparison of Outcomes between Hodgkin’s Lymphoma Patients Treated in and Outside Clinical Trials: A Study Based on the EORTC‐Dutch Late Effects Cohort‐linked Data.” European Journal of Haematology 110 (3): 243–52. doi:10.1111/ejh.13899.